Salvage surgery for recurrent primary nasopharyngeal carcinoma.
about
Validation of a prognostic scoring system for locally recurrent nasopharyngeal carcinoma treated by stereotactic radiosurgery.Benefits of local tumor excision and pharyngectomy on the survival of nasopharyngeal carcinoma patients: a retrospective observational study based on SEER database.Diagnosis of post-radiotherapy local failures in nasopharyngeal carcinoma: a prospective institutional study.Nasopharyngeal carcinoma: treatments and outcomes in the 20th century.Present status of management of nasopharyngeal carcinoma.Neoadjuvant and Concurrent Chemotherapy Have Varied Impacts on the Prognosis of Patients with the Ascending and Descending Types of Nasopharyngeal Carcinoma Treated with Intensity-Modulated RadiotherapyComparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis.Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy.Current treatment options for recurrent nasopharyngeal cancer.Critical appraisal of maxillary swing approach for nasopharyngeal carcinoma.The role of myringotomy and ventilation tube insertion in maxillary swing approach nasopharyngectomy: review of our 10-year experience.Radiation-induced squamous cell carcinoma of the nasopharynx after radiotherapy for nasopharyngeal carcinoma.Endoscopic endonasal nasopharyngectomy in selected cancers.Multivariate analysis of prognostic factors for salvage nasopharyngectomy via the maxillary swing approach.The challenge in treating locally recurrent T3-4 nasopharyngeal carcinoma: the survival benefit and severe late toxicities of re-irradiation with intensity-modulated radiotherapy.A triplet chemotherapy regimen of cisplatin, fluorouracil and paclitaxel for locoregionally recurrent nasopharyngeal carcinoma cases contraindicated for re-irradiation/surgery.The role of Epstein-Barr virus-encoded microRNA BART7 status of resection margins in the prediction of local recurrence after salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma.Stenting of the eustachian tube to prevent otitis media with effusion after maxillary swing approach nasopharyngectomy.The role of plasma Epstein-Barr virus DNA in the management of recurrent nasopharyngeal carcinoma.Prediction of surgical outcome using plasma Epstein-Barr virus dna and (18)F-FDG PET-CT scan in recurrent nasopharyngeal carcinoma.Effect of total dose and fraction size on survival of patients with locally recurrent nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: a phase 2, single-center, randomized controlled trial.Stage II recurrent nasopharyngeal carcinoma: Prognostic significance of retropharyngeal nodal metastasis, parapharyngeal invasion, and carotid encasement.Quality of life of patients after salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma.Long-term survival and late complications in intensity-modulated radiotherapy of locally recurrent T1 to T2 nasopharyngeal carcinoma.Combined transoral transnasal robotic-assisted nasopharyngectomy: a cadaveric feasibility study.Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy.Surgical salvage for recurrent retropharyngeal lymph node metastasis in nasopharyngeal carcinoma.
P2860
Q33436436-D8722102-0A9E-4D32-A6AA-5D01E4D74BDAQ33743611-863469E7-AE29-4A71-96A2-E41ABF928DB8Q34082518-229E6148-4A9A-433E-BA72-88A655367133Q34631533-D169F46D-2405-4586-A514-8734F0109A4DQ34734273-DCA19944-DBF5-4371-A991-C6ED70B465FCQ36174879-BBBBD4F6-00DF-4675-8416-389CC1E5C23BQ37222065-9BCAD9DB-60BD-4CA4-A8FD-084C7E20D19BQ37507369-4B0F5633-2A9C-4BD8-9885-AFBB309D6B00Q37791861-266023DE-FF0E-4C9A-A5D1-C97FAD3CA1ACQ37982129-30A2AEC9-CFD8-49EA-99F8-3C24D39892D6Q38041038-508F0696-10E1-455B-B1C7-99E977E9818DQ38101530-5EE92810-4AAB-4788-86A4-065F5A1A9AFEQ38114323-C61A7A32-5126-4743-96E0-357B50594E79Q38115742-770E2659-8CF8-42BB-9966-1FA6F6979F36Q38828315-E3801EAE-169D-4DD2-9266-8F9A59EF0030Q40689526-955A0E6E-0DBC-411B-95BB-F07FA2AC06B0Q41752446-AAFCB82F-4195-4212-83F6-88872A8F6B46Q43889630-679D179A-96BA-4987-9420-103E09F38AB5Q45351163-FD6C34F5-1D35-49F1-8FF3-11E934D072B0Q45367060-7E0670D0-6577-4D87-9094-CC6671396218Q47446967-FE74CE85-DC35-4191-AB5B-59FF2CF68702Q48103860-4A0D0726-9D7E-4090-A2D7-0223E2196E2BQ48516399-D11D6BE3-FCF8-484E-B802-2433E62009E1Q48525613-F4439773-A74B-467F-8773-A23C9C1B18B2Q51590170-99AB81E4-EF17-4B03-BA3F-5A86D395FC4EQ52602002-EBFFA154-C13F-4D10-8D88-3E61D5ED7E1BQ53117482-8A1352C3-6BA1-4C65-B540-8EB0875C4605
P2860
Salvage surgery for recurrent primary nasopharyngeal carcinoma.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Salvage surgery for recurrent primary nasopharyngeal carcinoma.
@ast
Salvage surgery for recurrent primary nasopharyngeal carcinoma.
@en
type
label
Salvage surgery for recurrent primary nasopharyngeal carcinoma.
@ast
Salvage surgery for recurrent primary nasopharyngeal carcinoma.
@en
prefLabel
Salvage surgery for recurrent primary nasopharyngeal carcinoma.
@ast
Salvage surgery for recurrent primary nasopharyngeal carcinoma.
@en
P1476
Salvage surgery for recurrent primary nasopharyngeal carcinoma
@en
P2093
P356
10.1016/S1040-8428(99)00069-4
P577
2000-02-01T00:00:00Z